Gamida Cell Gestione
Gestione criteri di controllo 2/4
Gamida Cell's CEO is Abbey Jenkins, appointed in Sep 2022, has a tenure of 1.67 years. total yearly compensation is $1.36M, comprised of 41.8% salary and 58.2% bonuses, including company stock and options. directly owns 0.38% of the company’s shares, worth $9.89K. The average tenure of the management team and the board of directors is 2.9 years and 4.9 years respectively.
Informazioni chiave
Abbey Jenkins
Amministratore delegato
US$1.4m
Compenso totale
| Percentuale dello stipendio del CEO | 41.8% |
| Mandato del CEO | 1.7yrs |
| Proprietà del CEO | 0.4% |
| Durata media del management | 2.9yrs |
| Durata media del Consiglio di amministrazione | 4.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Gamida Cell shares slide after stock offering
Sep 27Gamida appoints Emergent’s former head of vaccines as new CEO
Sep 19Gamida Cell Q2 2022 Earnings Preview
Aug 12Gamida stock rises 13% as FDA grants priority review to stem cell therapy omidubicel
Aug 01Does Gamida Cell (NASDAQ:GMDA) Have A Healthy Balance Sheet?
Feb 23
Gamida Cell: Recapping A Tough Year
Nov 02Gamida Cell (NASDAQ:GMDA) Has Debt But No Earnings; Should You Worry?
Nov 02Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$62m |
| Dec 31 2023 | US$1m | US$571k | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$77m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$80m |
| Dec 31 2022 | US$707k | US$157k | -US$79m |
Compensazione vs Mercato: Abbey's total compensation ($USD1.36M) is above average for companies of similar size in the US market ($USD661.07K).
Compensazione vs guadagni: Abbey's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
Abbey Jenkins (47 yo)
1.7yrs
Mandato
US$1,364,308
Compensazione
Ms. Abigail L. Jenkins, M.S. also known as Abbey, serves as a Director at XORTX Therapeutics Inc. since April 08, 2024. She is Independent Director of Aquestive Therapeutics, Inc. from April 1, 2024. She i...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 1.7yrs | US$1.36m | 0.38% $ 9.9k | |
| Chief Financial Officer | less than a year | US$1.06m | Nessun dato | |
| Chief Medical Officer & Chief Scientific Officer | 6.8yrs | US$1.34m | 0.33% $ 8.7k | |
| Vice President of Marketing & Account Management | 3.3yrs | Nessun dato | Nessun dato | |
| Chief Human Resource Officer | 1.5yrs | Nessun dato | Nessun dato | |
| Senior Vice President Finance & Operations | no data | Nessun dato | Nessun dato | |
| Scientific Advisor & Consultant | 2.8yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Global Operations & Manufacturing | 2.9yrs | Nessun dato | Nessun dato | |
| Chief of Staff | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Market Access | 3.5yrs | Nessun dato | Nessun dato | |
| Head of Global Information Technology | no data | Nessun dato | Nessun dato |
2.9yrs
Durata media
55.5yo
Età media
Gestione esperta: GMDA.Q's management team is considered experienced (2.9 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 1.7yrs | US$1.36m | 0.38% $ 9.9k | |
| Independent Director | 7.8yrs | US$179.77k | 0.10% $ 2.7k | |
| Independent Director | 4.9yrs | US$213.10k | 0.12% $ 3.2k | |
| Director | 7.8yrs | US$865.34k | 0.89% $ 23.4k | |
| Independent Chairwoman | 4.9yrs | US$209.17k | 0.11% $ 2.8k | |
| Independent Director | 1.9yrs | US$161.86k | 0.070% $ 1.8k |
4.9yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: GMDA.Q's board of directors are considered experienced (4.9 years average tenure).